See the DrugPatentWatch profile for annovera
Is Annovera Approved for Women Over 35?
Yes, Annovera, a vaginal ring contraceptive containing segesterone acetate and ethinyl estradiol, can be used by women over 35, including those approaching menopause. The FDA-approved labeling does not impose an upper age limit and supports continuous use for up to a year (13 cycles) without interruption.[1] Prescribers often recommend it for perimenopausal women seeking hormone-based birth control, as long as they meet general eligibility criteria for combined hormonal contraceptives.
Who Should Avoid Annovera Regardless of Age?
Women over 35 with specific risk factors face heightened contraindications due to the estrogen component, which increases risks like blood clots, stroke, and heart attack. Avoid if you:
- Smoke (10+ cigarettes/day).
- Have uncontrolled high blood pressure, diabetes with vascular issues, migraines with aura, or a history of breast cancer, blood clots, or heart disease.
These align with CDC Medical Eligibility Criteria (MEC Category 4: unacceptable health risk).[2][1]
How Does Age Affect Risks for Annovera Users?
Estrogen-containing contraceptives like Annovera carry elevated cardiovascular risks for women over 35, especially smokers—clot risk can rise 2-4 fold compared to younger users.[3] Non-smokers without other risks remain at MEC Category 2 (benefits generally outweigh risks).[2] Real-world data from post-marketing studies show similar efficacy (91% typical use) across ages 18-49, but monitoring for hypertension and lipids is advised annually after 35.[1]
What Do Women Over 35 Say About Using It?
Patient reviews on platforms like Drugs.com note Annovera works well for cycle control in perimenopause, with fewer hormone fluctuations than pills. Common complaints include ring expulsion (5-10% of users) and initial vaginal irritation, unrelated to age. Some report lighter periods or spotting resolution post-35.[4]
Annovera vs. Other Options for Women Over 35
| Option | Age Suitability Over 35 | Key Pros | Key Cons |
|--------|--------------------------|----------|----------|
| Annovera (ring) | Yes, if low-risk | Yearly supply, no daily dosing | Estrogen risks, $0-$800/year (insurance varies) |
| Mirena IUD (progestin-only) | Preferred (MEC 1) | 5-8 years, lighter bleeding | Insertion pain, $0-$1,300 |
| Paragard (copper IUD) | Yes (MEC 1) | Non-hormonal, 10+ years | Heavier periods |
| Progestin-only pill | Yes (MEC 2) | No estrogen | Strict daily timing |
Progestin-only methods edge out for smokers or high-risk women over 35.[2]
When to Talk to a Doctor Before Starting
Consult for personalized assessment—pap smears, mammograms, and STI screening matter more post-35. Annovera requires a prescription; remove if pregnancy suspected or after one year.[1]
[1]: FDA Annovera Label
[2]: CDC Contraceptive Guidance
[3]: ACOG Estrogen Risks
[4]: Drugs.com Annovera Reviews